POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 63 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $149,686 | +48.1% | 62,893 | +9.5% | 0.00% | – |
| Q2 2023 | $101,085 | +1584.8% | 57,435 | +3183.9% | 0.00% | – |
| Q1 2023 | $6,000 | +3536.4% | 1,749 | -94.4% | 0.00% | – |
| Q4 2022 | $165 | -100.0% | 31,224 | -72.4% | 0.00% | – |
| Q3 2022 | $400,000 | -33.8% | 113,187 | -51.7% | 0.00% | – |
| Q2 2022 | $604,000 | -57.7% | 234,184 | -26.5% | 0.00% | – |
| Q1 2022 | $1,428,000 | -29.6% | 318,676 | +7.0% | 0.00% | – |
| Q4 2021 | $2,027,000 | -21.5% | 297,782 | -15.9% | 0.00% | – |
| Q3 2021 | $2,581,000 | -17.6% | 354,065 | +13.2% | 0.00% | – |
| Q2 2021 | $3,134,000 | +5.6% | 312,694 | +0.6% | 0.00% | – |
| Q1 2021 | $2,969,000 | +4467.7% | 310,862 | +5129.0% | 0.00% | – |
| Q4 2020 | $65,000 | +44.4% | 5,945 | +18.8% | 0.00% | – |
| Q3 2020 | $45,000 | – | 5,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $9,254,000 | 2.96% |
| SECTORAL ASSET MANAGEMENT INC | 1,053,779 | $9,347,000 | 0.80% |
| Pentwater Capital Management LP | 4,879,490 | $43,281,000 | 0.56% |
| Vivo Capital, LLC | 926,449 | $8,218,000 | 0.48% |
| Boxer Capital, LLC | 1,251,055 | $11,097,000 | 0.38% |
| Ikarian Capital, LLC | 228,000 | $2,022,000 | 0.15% |
| Perceptive Advisors | 787,745 | $6,987,000 | 0.10% |
| Rock Springs Capital Management LP | 367,499 | $3,260,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 148,949 | $1,321,000 | 0.07% |
| PIPER SANDLER & CO. | 8,298 | $74,000 | 0.06% |